Tag: deep venous stenting
InterVene announces US$13 million Series A financing to advance Recana system...
InterVene recently announced the closing of its US$13 million Series A financing round. The financing was co-led by new investor Treo Ventures and existing...
Deep venous stenting determined “safe” with low rates of major complications
A recent analysis of deep venous stent placement has determined that the procedure is safe with low rates of major complications. Published in the...
Educate, educate, and educate again: The continuing quest for appropriate venous...
Prominent venous disease experts discuss venous stenting, appropriate care, and the pursuit of refined data and better education in a space where part of...
Blueflow venous stent for chronic iliofemoral venous disease “offers favourable primary...
Deep venous stenting with the Blueflow venous stent (Plus Medica) offers favourable primary patency, and is associated with significant continued improvement of symptom severity...
Early ultrasound surveillance key to predicting risk of re-intervention in deep...
An analysis of post-thrombotic disease patients who received a nitinol stent has found that ultrasound surveillance should occur at frequent intervals up to two...